Materials
and methods. In the first stage of a prospective study, 989 women of reproductive age were put through the method of continuous sampling. Based on the results of verifying the gynecological pathology, 350 patients who gave informed consent for participation in the second stage of the study, were divided into clinical groups for further comparative analysis of the prevalence of dysfunction of thyroid gland: I group – 159 (51.3%) patients with combined non-hormonal non-inflammatory pathology of reproductive organs and dyshormonal pathology of the mammary glands (genital endometriosis, adenomyosis / uterine leiomyoma in combination with endometrial hyperplasia), II group – 31 (8.9%) female with PCOS, III – 53 (15.1%) with endometriotic disease, IV group – 57 (16.3%) women with uterine leiomyoma. Absence of gynecological pathology and pathology of mammary glands at the time of the survey was found in 50 (14.3%) of women, which amounted to V group.
Results. Structural and functional changes of the thyroid gland were found in 53.4% of women, while the frequency of detection of diffuse goiter I–II st. did not differ between clinical groups (p>0.05). The prevalence of autoimmune thyroiditis was higher in patients with dyshormonal pathology of the reproductive system than in healthy women (p=0.0001). The euthyroid state with combined dyshormonal and proliferative pathology occurred 1.5 to 1.9 times less frequently than in patients of other groups (p≤0.0005). Subclinical hypothyroidism was diagnosed in 39,6% of the I group of women at 12.9%, 15.1% and 14.0% in the II, III and IV groups, respectively. At the same time, the incidence of subclinical hypothyroidism was 60.6% for the I group in women who had diffuse goiter and / or autoimmune thyroiditis, with 8.6% of the manifest hypothyroidism that was absent in women with PCOS, and the prevalence of endometriosis disease and uterine leiomyomies were 1.9% and 3.5%, respectively.
Conclusion. Thus, the results of a two-stage study of thyroid gland thyroid dysfunction in women with dyshormonal pathology of reproductive organs of non-inflammatory genesis confirm that dysfunction of the thyroid gland, especially hypothyroidism, is a serious problem for reproductive health, requiring changes in diagnostic and therapeutic approaches.
Key words: thyroid gland, autoimmune thyroiditis, hypothyroidism, reproductive health, non-inflammatory dyshormonal diseases of reproductive organs.
References
1. Bondar TN. 2008. Subklinicheskie narusheniya funktsii schitovidnoy zhelezy. Annals Mechnikov Institute 4:9–13.
2. Dedov II, Melnichenko GA. 2013. Endokrinologiya: natsionalnoe rukovodstvo. M, GEOTAR-Media:1072.
3. Klimov VS, Abaturova LO, Lyubimaya DR. 2017. Narushenie reproduktivnoy funktsii pri patologii schitovidnoy zhelezy. Molodoy uchenyi. 14(2):22-25. URL https://moluch.ru/archive/148/41871/ (data obrascheniya: 17.06.2017).
4. Fadeev VV. 2008. Verhniy referentnyiy uroven TTG – dostatochno li argumentov dlya ego izmeneniya. Probl. endokrinol. 54(1):46–50.
5. Shestakova TP. 2016. Subklinicheskiy gipotireoz – sovremennyiy vzglyad na problemu. RMZh. 1:6-8.
6. Alexander EK, Pearce EN, Brent GA, Brown RS et al. 2017. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid. 27(3):315-389. https://doi.org/10.1089/thy.2016.0457
7. American College of Obstetrics, Gynecologists Committee on Gynecologic P. ACOG Committee Opinion 483: Primary and preventive care: periodic assessments. Obstetrics and gynecology 117:1008-15. 2011. https://doi.org/10.1097/AOG.0b013e318219226e; PMid:21422880
8. Amino N, Tada H, Hidaka Y, Hashimoto K. 2002. Hashimoto’s disease and Dr. Hakaru Hashimoto. Endocr. J. 49:389-391. https://doi.org/10.1507/endocrj.49.389
9. Brabant РG, Duntas L, Monzani F et al. 2013. Management of Subclinical Hypothyroidism 2013 ETA Guideline. Eur. Thyroid. J. 2:215-228. https://doi.org/10.1159/000356507; PMid:24783053 PMCid:PMC3923601
10. Ladenson PW, Singer PA, Ain KB et al. 2000. American Thyroid Association guidelines for detection of thyroid dysfunction. Archives of internal medicine 160:1573-5. https://doi.org/10.1001/archinte.160.11.1573; PMid:10847249
11. Maruna P. 2006. Gynecological aspects of thyroid disorders. A review. Ceska Gynecol. 71(4):332–338. PMid:16956049
12. Männistö T, Vääräsmäki M, Pouta A et al. 2010. Thyroid dysfunction and autoantibodies during pregnancy as predictive factors of pregnancy complications and maternal morbidity in later life J. Clin. Endocrinol. Metab. 95(3):1084-1094. https://doi.org/10.1210/jc.2009-1904; PMid:20080846
13. Razvi S, Weaver JU, Vanderpump MP, Pearce SH. 2010. The incidence of ischemic heart disease and mortality in people with subclinical hypothyroidism: reanalysis of the Whickham Survey cohort. J. Clin. Endocrinol. Metab. 95(4):1734-1740. https://doi.org/10.1210/jc.2009-1749
14. Redmond GP. 2004. Thyroid dysfunction and women’s reproductive health. Thyroid. 14(1):515. https://doi.org/10.1089/105072504323024543
15. Toulis KA, Goulis DG, Venetis CA et al. 2010. Risk of spontaneous miscarriage in euthyroid women with thyroid autoimmunity undergoing IVF: a meta-analysis. Eur. J. Endocrinol. 162(4):643-652. https://doi.org/10.1530/EJE-09-0850
16. Walsh JP, Bremner AP, Feddema P et al. 2010. Thyrotropin and thyroid antibodies as predictors of hypothyroidism: a 13-year, longitudinal study of a community-based cohort using current immunoassay techniques J. Clin. Endocrinol. Metab. 95(3):1095-1104. https://doi.org/10.1210/jc.2009-1977
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.